Daily Roundup

SPZ.ASX IMB.ASX TLX.ASX EOS.ASX IPX.ASX

Smart Parking Expands US Footprint with American Parking Deal

Smart Parking Limited has snapped up American Parking for USD$12 million, bolstering its presence across the US to over 200 sites. The acquisition brings 54 locations in Oklahoma, Texas, and Arkansas into the fold, with American Parking having generated USD$8.0 million in revenues and USD$1.4 million in EBITDA during 2025. The deal, funded through existing cash reserves, debt facilities, and SPZ shares, is expected to be accretive to earnings per share from day one. The company continues to scout for further opportunities in the American parking market as it progresses along its growth trajectory.

Intelligent Monitoring Group Makes Massive Play in UK Security

In a transformative move, Intelligent Monitoring Group has agreed to acquire ADT's UK residential security business for GBP £180 million—a deal set to reshape the company's financial profile. The acquisition will inject USD$12.5 million in monthly recurring revenue from over 160,000 direct customers, expected to close in the first half of 2027. Perhaps most impressively, the transaction is anticipated to triple IMG's pro forma annualised EBITDA to A$130 million while delivering a 40% boost to earnings per share, pushing pro forma EPS to 9.0 cents. The company is financing the deal through a new A$448 million debt facility and vendor equity placement, sidestepping the need for external capital raises. IMG expects the acquisition to be materially accretive and provide a solid platform for future growth initiatives.

Telix Clears FDA Hurdle for Prostate Cancer Trial

Telix Pharmaceuticals has secured FDA alignment to advance its ProstACT Global Phase 3 trial for TLX591-Tx, a therapeutic candidate targeting metastatic castration-resistant prostate cancer. The regulatory body confirmed the safety data from Part 1 and greenlit the clinical protocol and statistical framework for Part 2, which will test three standard-of-care combination cohorts. Recruitment is already underway across approved jurisdictions including Australia, New Zealand, Canada, Türkiye, the UK, China, Singapore, and South Korea, with the trial targeting approximately 490 patients globally.

EOS Lands A$38m in New Defence Orders

Electro Optic Systems has secured roughly A$38 million in new sales orders that underscore demand for its defence capabilities. The company landed a USD$16 million (~A$23 million) contract for its Naval R400 Remote Weapon System from a new Middle East customer, with deliveries spanning seven years. Meanwhile, its MARSS division clinched an £8 million (~A$15 million) order from an existing Middle East client for a counter-drone command and training centre, expected to be substantially delivered during 2026 and 2027.

IperionX Unlocks High-Grade Critical Minerals in Tennessee

IperionX has completed its acquisition of the Camden critical minerals assets, gaining access to ultra-high-grade surface stockpiles enriched in titanium, zircon, and rare earth minerals. The assets, located adjacent to the company's Titan Project in Tennessee, boast grades 5 to 10 times higher than Titan's average, courtesy of historical silica sand operations that pre-processed the minerals into stockpiles. The pre-stripped Lower McNairy mineralization offers rapid access to high-grade seams, while established infrastructure on site could significantly de-risk development timelines and slash capital expenditure. IperionX is ramping up drilling campaigns and metallurgical testing to quantify resources and optimize recoveries, with a formal mineral resource estimate anticipated by year-end 2026.